Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Leverage Edu
company
About
AI-enabled marketplace designed to help students with their higher education and career growth plans
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $22M
- Industries
- Artificial Intelligence,Career Planning,EdTech,Education,Higher Education,Internet,Marketplace
- Founded date
- Apr 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Leverage Edu is an AI-enabled marketplace designed to help students with their higher education and career growth plans. It is one of India's leading/fastest growing ed-tech companies, transforming access to an exponential career growth, by democratising mentorship, breaking traditional systems, & helping the new student of today jump over the artificial high walls!
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$22M
Leverage Edu has raised a total of
$22M
in funding over 2 rounds. Their latest funding was raised on
Mar 21, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2022 | Series B | $22M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Leverage Edu is funded by 2 investors.
9Unicorns Accelerator Fund
and Mankind Pharma
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
9Unicorns Accelerator Fund
|
— | Series B |
Mankind Pharma
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
